A potential new antidepressant and antianxiety treatment with a unique mechanism of action has been developed by scientists at the University of Bath.
The compound has shown significant potential after studies in mice. The research is published in the British Journal of Pharmacology.
Around one in six adults will experience depression in their lifetimes. New drugs to treat depression in particular are needed because many existing antidepressants don’t work in up to 50% of patients. This new University of Bath compound, known as BU10119, works in a different way to the most common antidepressant drugs; selective serotonin reuptake inhibitors (SSRIs), and may therefore offer a new potential treatment for those in whom SSRIs don’t work.
Unlike SSRIs which target the serotonin system in the brain, BU10119 works by blocking receptors called kappa opioid receptors. Blocking these receptors has been shown to have anti-depressant like effects in mice.
In a series of laboratory trials, mice given BU10119 demonstrated behaviours consistent with providing antidepressant–like effects.
Dr Sarah Bailey, Senior Lecturer in the Department of Pharmacy & Pharmacology at the University of Bath, said: “I’m really quite excited by the potential of this compound. Developing new medicines is why I got into pharmacology and, in 20 years of research, this is the closest I have come to a new compound that might translate towards the clinic. It’s promising, but that said, we are still at an early stage, these experiments are in mice and further research is still required for example to establish safety.
“SSRIs can work very well for some patients, but we know they don’t work for everyone which is one reason why developing new antidepressant and antianxiety drugs could be really beneficial.”
The researchers were inspired to develop the compound after previous University of Bath research showed that a combination of two existing drugs, buprenorphine and naltrexone, had potential as an antidepressant. BU10119 combines the effects of this combination in one drug.
Professor Stephen Husbands, Head of Medicinal Chemistry at the University of Bath added: “This research builds on our previous work which showed that combining buprenorphine and naltrexone can give antidepressant effects in mice. By combining the effects of both drugs in one molecule we hope that a safe and effective drug will eventually be the outcome. BU10119 is part of a series of compounds now licensed to, and under development with, Orexigen Therapeutics.”
The study was funded a by a National Institute on Drug Abuse grant and a PhD scholarship from the Government of Saudi Arabia.
The University of Bath has signed the Concordat on Openness on Animal Research. The University is committed to enhancing our communications with the media and public about our research using animals. Find out more: http://www.bath.ac.uk/collections/animal-research/
The Latest on: Depression and anxiety
- Depression is different for everyone. Here’s what it’s like for me. on May 25, 2019 at 3:07 am
I have irrational bouts of anxiety. I have random FedEx deliveries ... Ram Dass taught me -- is instead of identifying with the depression and saying, "I am depressed" -- although, that is how ... […]
- Thought of unemployment causes extreme anxiety, depression on May 24, 2019 at 9:10 pm
Adapted from a recent online discussion. Dear Carolyn: I’m 49 and probably about to be unemployed because of job elimination. Not struggling financially, thank goodness. But feeling anxious and ... […]
- The Treasure Valley's newest option to treat anxiety and depression in teens on May 24, 2019 at 4:02 pm
Dr. Chris Streeter, a medical doctor for St. Luke's Children's Center for neuro-behavioral medicine, stops by KTVB to discuss some of the options available for children to treat depression and anxiety ... […]
- Therapy dogs help people battle stress, loss and depression, advocate says. They strengthen our mental health. on May 24, 2019 at 2:40 pm
soon after their son/brother Kenny died by suicide following a long battle with severe depression and anxiety. Their mission is to save lives by educating students about mental health, related ... […]
- Vision loss linked with anxiety, depression - and vice versa on May 24, 2019 at 9:54 am
Older adults with impaired vision are more likely to have symptoms of anxiety and depression, and older adults with symptoms of anxiety or depression are more likely to develop vision impairment, ... […]
- If I Take Medicine for My Anxiety/Depression, Does that Mean I’m Not Trusting God? on May 23, 2019 at 5:28 am
Editor’s Note: Crosswalk's Singles Advice is an advice column for singles featuring an anonymous question from a Crosswalk.com reader with a thoughtful, biblical reply from one of our single editors. ... […]
- What’s the Difference Between Bipolar Disorder and Depression? on May 22, 2019 at 6:39 am
"You can think of bipolar as cycling between highs and lows," says George Livengood, assistant national director of operations at the Discovery Mood and Anxiety Program in Southern California and ... […]
- Exercise Could Be Prescribed to Treat Anxiety and Depression on May 21, 2019 at 7:11 am
Scientists behind a study showing exercise can ease the symptoms of disorders like depression hope working out could one day be prescribed to mental health patients in hospitals. The team behind the ... […]
- Autism in Women: Mine Was Misdiagnosed as Depression and Anxiety on May 21, 2019 at 1:23 am
Autism in women looks to be a condition that's been less understood than it should. Up until recently, it was thought that the male/female gender split stood at 3:1 – but it now appears that the ... […]
- How to cope with depression and anxiety in the workplace on May 20, 2019 at 12:15 pm
Nearly one in three adults (32%) say they are more anxious than they were last year, according to a recent report by the American Psychiatric Association (APA). Only a quarter (24%) report being ... […]
via Google News and Bing News